Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation.
about
Efficacy and safety of rabeprazole in non-steroidal anti-inflammatory drug-induced ulcer in Japan.Individualized therapy for gastroesophageal reflux disease: potential impact of pharmacogenetic testing based on CYP2C19.A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.Pharmacokinetics and Pharmacodynamics of Azeloprazole Sodium, a Novel Proton Pump Inhibitor, in Healthy Japanese Volunteers.
P2860
Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Plasma concentration of rabepr ...... and intragastric pH elevation.
@en
Plasma concentration of rabepr ...... and intragastric pH elevation.
@nl
type
label
Plasma concentration of rabepr ...... and intragastric pH elevation.
@en
Plasma concentration of rabepr ...... and intragastric pH elevation.
@nl
prefLabel
Plasma concentration of rabepr ...... and intragastric pH elevation.
@en
Plasma concentration of rabepr ...... and intragastric pH elevation.
@nl
P2093
P2860
P1476
Plasma concentration of rabepr ...... and intragastric pH elevation.
@en
P2093
Hiro-o Matsushita
Hiro-o Yamano
Seiko Yanagiwara
P2860
P304
P356
10.1111/J.1440-1746.2007.05104.X
P577
2007-08-27T00:00:00Z